MyFinsight
Home
Blog
About
Contact
Download
Download image
Net change in cash
and cash...
-$52,965K
Proceeds from maturities
of marketable...
$39,100K
Proceeds from sale of
equity securities
$2,681K
Proceeds from sale of
property and equipment
$7K
Stock-based compensation
expense
$9,776K
Depreciation and
amortization
$3,929K
Accounts payable
$3,193K
Other accrued and
current liabilities
$2,755K
Accounts receivable
-$1,075K
Other
-$532K
Operating lease assets
-$371K
Proceeds from
contributions to the employee...
$1,267K
Proceeds from exercise of
common stock options
$322K
Net cash used in
investing activities
-$25,803K
Net cash used in
operating activities
-$22,129K
Net cash used in
financing activities
-$5,033K
Canceled cashflow
$41,788K
Canceled cashflow
$21,631K
Canceled cashflow
$1,589K
Net revenues from
external customers
$83,679K
Purchases of marketable
investment securities
$55,136K
Accrued compensation
-$19,176K
Net loss
-$14,522K
Payment of employees
taxes on vested...
$6,598K
Purchases of property and
equipment
$12,455K
Canceled cashflow
$83,679K
Prepaid expenses and
other current assets
$6,667K
Net (gains) losses
on equity...
$2,022K
Other assets
$530K
Accretion of discounts on
marketable investment...
$454K
Inventory
$207K
Operating lease
liabilities
-$172K
Deferred income taxes
-$10K
Repayment of principal
portion of finance lease...
$24K
Personnel costs
$58,367K
Organizational and marketing
costs
$15,594K
Other segment items
$12,254K
Inventory usage
$6,437K
Professional services
$3,007K
Clinical studies and
publication costs
$2,542K
Back
Back
Cash Flow
CASTLE BIOSCIENCES INC (CSTL)
CASTLE BIOSCIENCES INC (CSTL)
source: myfinsight.com